|
MED28 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.400530E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.30219999997061E-06 |
| Normal-vs-Stage2 |
2.382200E-01 |
| Normal-vs-Stage3 |
6.246500E-02 |
| Normal-vs-Stage4 |
2.871200E-01 |
| Stage1-vs-Stage2 |
1.212450E-01 |
| Stage1-vs-Stage3 |
8.284100E-02 |
| Stage1-vs-Stage4 |
2.358300E-04 |
| Stage2-vs-Stage3 |
9.303600E-01 |
| Stage2-vs-Stage4 |
9.735900E-02 |
| Stage3-vs-Stage4 |
2.587900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.574880E-04 |
| Normal-vs-AfricanAmerican |
5.942500E-03 |
| Normal-vs-Asian |
2.817800E-01 |
| Caucasian-vs-AfricanAmerican |
7.616600E-01 |
| Caucasian-vs-Asian |
5.882000E-01 |
| AfricanAmerican-vs-Asian |
6.924400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.42629999999133E-05 |
| Normal-vs-Female |
4.911800E-02 |
| Male-vs-Female |
3.128200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.235700E-02 |
| Normal-vs-Extreme_Weight |
4.22620000000151E-05 |
| Normal-vs-Obese |
4.781000E-03 |
| Normal-vs-Extreme_Obese |
1.261570E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.061400E-01 |
| Normal_Weight-vs-Obese |
8.857000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.866000E-01 |
| Extreme_Weight-vs-Obese |
1.946190E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.716000E-01 |
| Obese-vs-Extreme_Obese |
6.014800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.040600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.717580E-03 |
| Normal-vs-Age(61-80Yrs) |
1.154800E-04 |
| Normal-vs-Age(81-100Yrs) |
2.040800E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.434000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.165000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.237590E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.582200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.193390E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.119400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.53449999995559E-06 |
| Normal-VS-Type2 PRCC |
7.242700E-03 |
| Normal-VS-KIRP CIMP |
3.892600E-01 |
| Normal-VS-Unclassified PRCC |
2.130500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.395580E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.524000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.808100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.440070E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.704800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.192000E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.213800E-04 |
| Normal-vs-N1 |
8.316800E-01 |
| Normal-vs-N2 |
2.915400E-01 |
| N0-vs-N1 |
6.722600E-03 |
| N0-vs-N2 |
2.202200E-02 |
| N1-vs-N2 |
4.046200E-01 |
|
|
